Reafferon-Lipint capsules 500000 me 10 pcs

Pharmacotherapeutic group: cytokine.
ATC code: L03AB05

Pharmacological and immunobiological properties:

The drug has immunomodulatory and antiviral effect.
Human recombinant interferon alfa-2b which is the active substance of the preparation is synthesized by bacterial cells of Escherichia coli strain SG-20050/pIF16, which have a gene of human interferon alfa-2b built into their genetic apparatus. It is a protein containing 165 amino acids and is identical in its characteristics and properties to human leukocyte interferon alfa-2b.
The antiviral effect of interferon alfa-2b is shown during the period of virus reproduction by active involvement in cell metabolic processes. Interferon, interacting with specific receptors on the cell surface, initiates a number of intracellular changes, including the synthesis of specific cytokines and enzymes (2-5-adenylate synthetase and protein kinase), the action of which inhibits the formation of viral protein and viral ribonucleic acid in the cell.
Immunomodulatory action of interferon alfa-2b is manifested by the increase of phagocytic activity of macrophages, strengthening of specific cytotoxic effect of lymphocytes on the target cells, alteration of quantitative and qualitative composition of secreted cytokines, alteration of functional activity of immunocompetent cells, alteration of production and secretion of intracellular proteins.

Indications

Active ingredient

Composition

How to take, the dosage

Interaction

Special Instructions

Synopsis

Contraindications

Side effects

Overdose

Pregnancy use

Similarities